Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03897075
Brief Title: Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

First Submitted : March 27, 2019
First Submitted that Met QC Criteria : March 28, 2019
First Posted : April 1, 2019

Last Update Submitted that Met QC Criteria : April 12, 2021
Last Update Posted : April 13, 2021